Clinical ecaluation of surgical treatment and intra-arterial infusion immunochemotherapy for hepatocellular carcinoma

肝細胞癌の切除成績と皮下埋込式リザーバー動注療法の意義

Clinical ecaluation of surgical treatment and intra-arterial infusion immunochemotherapy for hepatocellular carcinoma

Creators Shimizu Ryoichi

Creators Uchiyama Tetsuji

Creators Nishihara Kenji

Creators Yano Kazuma

Creators Nishida Minekatsu

Creators Okimura Eiji

Creators Sakatat Koichiro

Creators Nishikawa Masahiro

Creators Hazama Syoichi

Creators Yoshino Shigefumi

Creators Iizuka Norio

Creators Hamanaka Yuichiro

Creators Oka Masaaki

Creators Mizuta Eishi

Creators Murakami Takuo

Creators Suzuki Takashi

During the past 4 years, 41 patients with hepatocellular carcinoma were treated in our clinic. Ninety precent od these patients had mild or severe liver dysfunction due to cirrhosis or chronic hepatitis, and the various types of liver resections were performed on 39 patients. The cummulative 3-years survival rate excluding the postoperative death cases was 75 percent. The intra-artetial infusion immunochemotherapy using totally implanted drug delivery system was further perdormed on five patients with noncurative surgery, among whom a 57-year-old woman showed complete response to intra-srtetially administered recombinant interleukin-2.

[ISSN]0513-1731

[NCID]AN00243156